To the best of our knowledge, among tubulins, only the aberrant expression of tubulin beta-3 (TUBB3) has been shown to correlate with the resistance to paclitaxel in ovarian, breast and lung cancers [112,113,114] and to docetaxel in gastric cancer [115]. Here, TUBB3 is linked to lung cancer.